TrialThe Lancet. Infectious diseases2023

Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

Sophie Welsche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.